TR200907237A2 - Tiotropium dry powder combination - Google Patents

Tiotropium dry powder combination

Info

Publication number
TR200907237A2
TR200907237A2 TR2009/07237A TR200907237A TR200907237A2 TR 200907237 A2 TR200907237 A2 TR 200907237A2 TR 2009/07237 A TR2009/07237 A TR 2009/07237A TR 200907237 A TR200907237 A TR 200907237A TR 200907237 A2 TR200907237 A2 TR 200907237A2
Authority
TR
Turkey
Prior art keywords
dry powder
powder combination
tiotropium
tiotropium dry
combination
Prior art date
Application number
TR2009/07237A
Other languages
Turkish (tr)
Inventor
B�Lg�� Mahmut
Original Assignee
B�Lg�� Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by B�Lg�� Mahmut filed Critical B�Lg�� Mahmut
Priority to TR2009/07237A priority Critical patent/TR200907237A2/en
Priority to EP10787588A priority patent/EP2480287A2/en
Priority to PCT/TR2010/000184 priority patent/WO2011037550A2/en
Publication of TR200907237A2 publication Critical patent/TR200907237A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4741—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Mevcut buluş, solunum yolları rahatsızlıklarında kullanılmak üzere, tiotropium aktif maddesinin etkili miktarlardaki kromolin türevi bir madde ile birlikte formüle edildiği inhalasyon yoluyla kullanılacak bir ilaç bileşimine dairdir.The present invention relates to a pharmaceutical composition for use by inhalation in which the active agent tiotropium is formulated together with an effective amount of a cromolyn derivative for use in respiratory diseases.

TR2009/07237A 2009-09-23 2009-09-23 Tiotropium dry powder combination TR200907237A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
TR2009/07237A TR200907237A2 (en) 2009-09-23 2009-09-23 Tiotropium dry powder combination
EP10787588A EP2480287A2 (en) 2009-09-23 2010-09-22 Dry powder combination of tiotropium
PCT/TR2010/000184 WO2011037550A2 (en) 2009-09-23 2010-09-22 Dry powder combination of tiotropium

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2009/07237A TR200907237A2 (en) 2009-09-23 2009-09-23 Tiotropium dry powder combination

Publications (1)

Publication Number Publication Date
TR200907237A2 true TR200907237A2 (en) 2011-04-21

Family

ID=43643869

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2009/07237A TR200907237A2 (en) 2009-09-23 2009-09-23 Tiotropium dry powder combination

Country Status (3)

Country Link
EP (1) EP2480287A2 (en)
TR (1) TR200907237A2 (en)
WO (1) WO2011037550A2 (en)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8712251D0 (en) * 1987-05-23 1987-07-01 Fisons Plc Formulation
DE3931041C2 (en) 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Esters of thienyl carboxylic acids with amino alcohols, their quaternization products, processes for their preparation and medicaments containing them
GB9006233D0 (en) 1990-03-20 1990-05-16 Kenrick & Jefferson Ltd Forms,for use,for example,as parking tickets
CN1150890C (en) * 1998-08-04 2004-05-26 杰格研究股份公司 Medicinal aerosol formulation
GB0009592D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory combinations
HUP0301377A3 (en) * 2000-10-31 2005-12-28 Boehringer Ingelheim Pharma Combination pharmaceutical composition in form of inhalative solution containing a tiotropium salt
WO2006076222A2 (en) * 2005-01-10 2006-07-20 Glaxo Group Limited Pharmaceutical formulations

Also Published As

Publication number Publication date
WO2011037550A3 (en) 2011-09-15
WO2011037550A2 (en) 2011-03-31
EP2480287A2 (en) 2012-08-01

Similar Documents

Publication Publication Date Title
SV2009003236A (en) REPLACED DIHYDROPIRAZOLONES FOR THE TREATMENT OF CARDIOVASCULAR AND HEMATOLOGICAL DISEASES
EA201291306A1 (en) COMPOSITION OF DRY POWDER CONTAINING ANTIMUSCARINE MEANS
ECSP13012612A (en) DERIVATIVES OF QUINAZOLIN-4- (3H) -ONA USED AS INHIBITORS OF P13 CINASA
MX2011011733A (en) Dihydroorotate - dehydrogenasee inhibitors as virostatic compounds.
HN2010001920A (en) DIHYDROPIRAZOLONAS REPLACED AS INHIBITORS OF HIF- PROPIL-4-HYDROXYLASE
MX360554B (en) Compositions comprising and methods of using inhibitors of sodium-glucose cotransporters 1 and 2.
TR201008226A2 (en) An inhalation device containing capsules.
CU20100111A7 (en) 4- (4-CIANO-2-TIOARIL) DIHYDROPIRIMIDINONES AND ITS USE FOR THE TREATMENT AND PREVENTION OF PULMONARY AND CARDIOVASCULAR DISEASES
TR200803522A1 (en) Easy to use inhalation device.
CU20130072A7 (en) 1 H-PIRAZOL-5-SUBSTITUTED SODIUM OLATO
TR201000733A2 (en) Pharmaceutical compositions comprising fluticasone, tiotropium and sodium chromoglycate.
MX378056B (en) ORAL CARE COMPOSITIONS.
BRPI1005932A2 (en) compound, pharmaceutical composition for inhalation and inhaler
TR200907917A2 (en) Dry powder inhaler.
PH12016500577B1 (en) Piperazine derivatives and the use thereof as medicament
TR201205852A2 (en) Improved new dry powder formulation.
TR200909792A2 (en) Dry powder combination containing tiotropium, corticosteroid and a combination of chromoglycic acid derivative
TR200907237A2 (en) Tiotropium dry powder combination
TR200803525A2 (en) Powder inhaler.
TR200909790A2 (en) Combination of dry powder containing a combination of tiotropium, formoterol and a chromoglycic acid derivative.
TR201105367A2 (en) A dry powder formulation with improved flow properties.
TR200909789A2 (en) Dry powder combination containing tiotropium, budesonide and a chromoglycic acid derivative combination
TR200909788A2 (en) Dry powder formulation suitable for inhalation with tiotropium
TR200909793A2 (en) Combination of dry powder containing a combination of tiotropium, mometasone and a chromoglycic acid derivative.
TR201007251A2 (en) Calcium channel blocker formulation.